References
- Aghajani, M., Shahverdi, A. R., Rezayat, S. M., Amini, M. A., & Amani, A. (2013). Preparation and optimization of acetaminophen nanosuspension through nanoprecipitation using microfluidic. Pharmaceutical Development and Technology, 18, 609–618.10.3109/10837450.2011.649854
- Ain-Ai, A., & Gupta, P. K. (2008). Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound. International Journal of Pharmaceutics, 351, 282–288.10.1016/j.ijpharm.2007.09.029
- Amani, A., York, P., Chrystyn, H., Clark, B. J., & Do, D. Q. (2008). Determination of factors controlling the particle size in nanoemulsions using Artificial Neural Networks. European Journal of Pharmaceutical Sciences, 35, 42–51.10.1016/j.ejps.2008.06.002
- Chen, C. Y., Wang, Y. F., Huang, W. R., & Huang, Y. T. (2003). Nickel induces oxidative stress and genotoxicity in human lymphocytes. Toxicology and Applied Pharmacology, 189, 153–159.10.1016/S0041-008X(03)00086-3
- Dong, F., Dong, X., Zhou, L., et al. (2016). Doxorubicin-loaded biodegradable self-assembly zein nanoparticle and its anti-cancer effect: Preparation, in vitro evaluation, and cellular uptake. Colloids and Surfaces B: Biointerfaces, 140, 324–331.10.1016/j.colsurfb.2015.12.048
- Hans, M., Yu, X., Guo, Y., Wang, Y., Kuang, H., & Wang, X (2014). Honokiol nanosuspensions: Preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system. Colloids Surf B Biointerfaces, 116, 114–120.
- Hu, J. H., Johnston, K. P., & Williams, R. O. (2004). III. Rapid dissolving high potency danazol powders produced by spray freezing into liquid process. International Journal of Pharmaceutics, 271, 145–154.10.1016/j.ijpharm.2003.11.003
- Lasagna, L., Owens, A. H., Jr, Shnider, B. I., & Gold, L. (1961). Toxicity after large doses of noscapine. Cancer Chemother Rep., 15, 33–34.
- Matteucci, M. E., Hotze, M. A., Johnston, K. P., & Williams, R. O. (2006). III. Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir, 22, 8951–8959.10.1021/la061122t
- deMello, J., & deMello, A. (2004a). Microscale reactors: Nanoscale products. Lab on a Chip , 4(2), 11N–15N.
- deMello, J, & deMello, A. (2004b). Devices: An artificial neural networks study. Pharmaceutical Development and Technology , 18, 609–618.
- Merisko-Liversidge, E., Liversidge, G. G., & Cooper, E. R. (2003). Nanosizing: A formulation approach for poorly-water-soluble compounds. European Journal of Pharmaceutical Sciences, 18, 113–120.10.1016/S0928-0987(02)00251-8
- Müller, R. H., Jacobs, C., & Kayser, O. (2001). Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Advanced Drug Delivery Reviews, 47, 3–19.10.1016/S0169-409X(00)00118-6
- Wu, L., Zhang, J., & Watanabe, W. (2011). Physical and chemical stability of drug nanoparticles. Advanced Drug Delivery Reviews, 63, 456–469.10.1016/j.addr.2011.02.001
- Zhao, H., Wang, J. X., Wang, Q. A., Chen, J. F., & Yun, J. (2007). Controlled liquid antisolvent precipitation of hydrophobic pharmaceutical nanoparticles in a microchannel reactor. Industrial & Engineering Chemistry Research, 46, 8229–8235.10.1021/ie070498e